Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II

To prospectively validate the SYNTAX Score II and forecast the outcomes of the randomized Evaluation of the Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) Trial. Evaluation of the Xience Everolimus Eluting Stent vs. Coro...

Full description

Saved in:
Bibliographic Details
Published in:European heart journal 2015-05, Vol.36 (20), p.1231-1241
Main Authors: Campos, Carlos M, van Klaveren, David, Farooq, Vasim, Simonton, Charles A, Kappetein, Arie-Pieter, Sabik, 3rd, Joseph F, Steyerberg, Ewout W, Stone, Gregg W, Serruys, Patrick W
Format: Article
Language:English
Subjects:
Aged
Coronary Artery Bypass - methods
Coronary Artery Bypass - mortality
Coronary Artery Disease - mortality
Coronary Artery Disease - therapy
Decision Support Systems, Clinical
Drug-Eluting Stents
Everolimus - administration & dosage
Female
Humans
Immunosuppressive Agents - administration & dosage
Male
Middle Aged
Myocardial Revascularization - methods
Myocardial Revascularization - mortality
Percutaneous Coronary Intervention - methods
Percutaneous Coronary Intervention - mortality
Peripheral Vascular Diseases - complications
Peripheral Vascular Diseases - mortality
Prospective Studies
Pulmonary Disease, Chronic Obstructive - complications
Pulmonary Disease, Chronic Obstructive - mortality
Severity of Illness Index
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To prospectively validate the SYNTAX Score II and forecast the outcomes of the randomized Evaluation of the Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) Trial. Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization is a prospective, randomized multicenter trial designed to establish the efficacy and safety of percutaneous coronary intervention (PCI) with the everolimus-eluting stent compared with coronary artery bypass graft (CABG) surgery in subjects with unprotected left-main coronary artery (ULMCA) disease and low-intermediate anatomical SYNTAX scores (
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehu518